NFE2L2 and familial pancreatic carcinoma: In cancer cells, several oncogenes increase NRF2 transcription to promote ROS detoxification and tumorigenesis, whereas the deletion of NRF2 promotes DNA damage and suppresses tumorigenesis in pancreatic cancer cells [131].